Principal Securities’s CureVac CVAC Stock Holding History

Principal Securities’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-173	Closed	-$932	–	1804
2025 Q3	$932	Sell	173 -118	-41%	-$639	﹤0.01%	3422
2025 Q2	$1.58K	Hold	291	–	–	﹤0.01%	3212
2025 Q1	$992	Hold	291	–	–	﹤0.01%	3210
2024 Q4	$992	Hold	291	–	–	﹤0.01%	3203
2024 Q3	$856	Buy	291 +114	+64%	+$376	﹤0.01%	3168
2024 Q2	$602	Sell	177 -56	-24%	-$183	﹤0.01%	3169
2024 Q1	$706	Sell	233 -7	-3%	-$25	﹤0.01%	3092
2023 Q4	$1.01K	Buy	+240	New	+$1.3K	﹤0.01%	2954

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Principal Securities's CVAC Position: Q4 2025 in Review

Principal Securities sold out of CureVac (CVAC) in Q4 2025, closing a stake of 173 shares — an estimated $932 sold.

Principal Securities first reported a position in CVAC in Q4 2023 and held it in 8 quarters. The position peaked at $1.58K in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Principal Securities reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Principal Securities sold 173 CureVac shares in Q4 2025, an estimated $932.
Principal Securities first reported a position in CureVac in Q4 2023 and held it in 8 quarters.
Principal Securities's CureVac position peaked at $1.58K in Q2 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.